GENDRON PAUL ANDREW 4

What Happened
Paul Andrew Gendron, a director of InfuSystem Holdings, purchased 5,000 shares of INFU in open-market transactions on May 8, 2026. The reported weighted-average price was $8.88 per share, for a total reported outlay of approximately $44,400. This is a purchase (insider buy), which many investors view as a clearexpression of alignment with the company, though it does not prove future performance.

Key Details

• Transaction date: 2026-05-08; Filing date: 2026-05-12 (filed four days after the trade).
• Transaction type/code: Open market purchase (P). Reported weighted-average price: $8.88; total reported value: $44,400.
• Shares purchased: 5,000. Shares owned after transaction: not specified in the filing.
• Footnote: The $8.88 price is a weighted average because the shares were acquired in multiple transactions; the reporting person will provide per-fill details upon request (Footnote F1).
• No indication in the filing of a 10b5-1 plan, gift, option exercise, or tax-withholding event.

Context
Director purchases are often watched by retail investors as a sign of confidence, but this is a relatively modest $44k buy and should be weighed with other data. The footnote confirms multiple executions at different prices; you can request full per-transaction pricing from the company or the SEC staff if you need exact fills.